Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
- Author
- Michele Sabbah, Shahin Emami, Gerard Redeuilh, Sylvia Julien, Gregoire Prevost, Amazia Zimber, Radia Ouelaa, Marc Bracke (UGent) , Olivier De Wever (UGent) and Christian Gespach
- Organization
- Keywords
- PROTEIN-KINASE-C, GROWTH-FACTOR RECEPTOR, Src, Receptor tyrosine kinases, SQUAMOUS-CELL CARCINOMA, NF-KAPPA-B, AKT, WISP-2 and-3, NF-kappa B, GPCR, Notch, DEPENDENT SIGNALING PATHWAYS, E-CADHERIN EXPRESSION, FOCAL ADHESION KINASE, TGF beta, REGULATES E-CADHERIN, MicroRNAs, Wnt/PKC, INTEGRIN-LINKED KINASE, HUMAN BREAST-CANCER
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 2.15 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-747016
- MLA
- Sabbah, Michele, et al. “Molecular Signature and Therapeutic Perspective of the Epithelial-to-Mesenchymal Transitions in Epithelial Cancers.” DRUG RESISTANCE UPDATES, vol. 11, no. 4–5, 2008, pp. 123–51, doi:10.1016/j.drup.2008.07.001.
- APA
- Sabbah, M., Emami, S., Redeuilh, G., Julien, S., Prevost, G., Zimber, A., … Gespach, C. (2008). Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. DRUG RESISTANCE UPDATES, 11(4–5), 123–151. https://doi.org/10.1016/j.drup.2008.07.001
- Chicago author-date
- Sabbah, Michele, Shahin Emami, Gerard Redeuilh, Sylvia Julien, Gregoire Prevost, Amazia Zimber, Radia Ouelaa, Marc Bracke, Olivier De Wever, and Christian Gespach. 2008. “Molecular Signature and Therapeutic Perspective of the Epithelial-to-Mesenchymal Transitions in Epithelial Cancers.” DRUG RESISTANCE UPDATES 11 (4–5): 123–51. https://doi.org/10.1016/j.drup.2008.07.001.
- Chicago author-date (all authors)
- Sabbah, Michele, Shahin Emami, Gerard Redeuilh, Sylvia Julien, Gregoire Prevost, Amazia Zimber, Radia Ouelaa, Marc Bracke, Olivier De Wever, and Christian Gespach. 2008. “Molecular Signature and Therapeutic Perspective of the Epithelial-to-Mesenchymal Transitions in Epithelial Cancers.” DRUG RESISTANCE UPDATES 11 (4–5): 123–151. doi:10.1016/j.drup.2008.07.001.
- Vancouver
- 1.Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, Zimber A, et al. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. DRUG RESISTANCE UPDATES. 2008;11(4–5):123–51.
- IEEE
- [1]M. Sabbah et al., “Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers,” DRUG RESISTANCE UPDATES, vol. 11, no. 4–5, pp. 123–151, 2008.
@article{747016,
author = {{Sabbah, Michele and Emami, Shahin and Redeuilh, Gerard and Julien, Sylvia and Prevost, Gregoire and Zimber, Amazia and Ouelaa, Radia and Bracke, Marc and De Wever, Olivier and Gespach, Christian}},
issn = {{1368-7646}},
journal = {{DRUG RESISTANCE UPDATES}},
keywords = {{PROTEIN-KINASE-C,GROWTH-FACTOR RECEPTOR,Src,Receptor tyrosine kinases,SQUAMOUS-CELL CARCINOMA,NF-KAPPA-B,AKT,WISP-2 and-3,NF-kappa B,GPCR,Notch,DEPENDENT SIGNALING PATHWAYS,E-CADHERIN EXPRESSION,FOCAL ADHESION KINASE,TGF beta,REGULATES E-CADHERIN,MicroRNAs,Wnt/PKC,INTEGRIN-LINKED KINASE,HUMAN BREAST-CANCER}},
language = {{eng}},
number = {{4-5}},
pages = {{123--151}},
title = {{Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers}},
url = {{http://doi.org/10.1016/j.drup.2008.07.001}},
volume = {{11}},
year = {{2008}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: